James Basta Sells $95.8K of Intellia Therapeutics Inc (NTLA) — SEC Form 4, Jan 07, 2026

Open-Market Net Sale · SEC Form 4

−$95,756

Equity position changed by -9.3%

Reporting Owner

James Basta

TXN 2026-01-05 · FILED 2026-01-07

Equity Position 102K sh 111,925 → 101,528

Equity Change -9.3% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Intellia Therapeutics Inc

NTLA CIK 0001652130

Reporting Owner

Name	Relationship
James Basta CIK 0001792726	GC

James Basta at Intellia Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $112,444

More from this insider at Intellia Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2026-01-05	S - Sale	10,397 D	$9.21	-$95,756	101,528	Direct

Footnotes (1)

F1: Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person. Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 5 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Intellia Therapeutics Inc

GET /v1/forms/4/0001193125-26-006291 API docs